Federated Hermes’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Sell
23,613
-9,129
-28% -$31K ﹤0.01% 1589
2026
Q1
$57.6K Buy
32,742
+29,800
+1,013% +$64.6K ﹤0.01% 1665
2025
Q4
$6.91K Buy
2,942
+308
+12% +$842 ﹤0.01% 1865
2025
Q3
$8.06K Buy
+2,634
New +$7.52K ﹤0.01% 1901

Other funds holding CLOV

Federated Hermes's CLOV Position: Q2 2026 in Review

Federated Hermes reduced its Clover Health Investments (CLOV) stake by 28% in Q2 2026, selling an estimated $31K and leaving 23,613 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

Federated Hermes first reported a position in CLOV in Q3 2025 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Federated Hermes held 23,613 shares of Clover Health Investments worth $124K as of Q2 2026.
  • Federated Hermes sold 9,129 Clover Health Investments shares in Q2 2026, an estimated $31K.
  • Clover Health Investments made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1589 holding.
  • Federated Hermes first reported a position in Clover Health Investments in Q3 2025 and has held it in 4 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.